Association Between Rewarming Rate and Survival and Neurologic Outcome of Accidental Hypothermia summary

What is PACUPod: Critical Care?

PACUPod is your trusted source for evidence-based insights tailored to advanced clinical pharmacists and physicians. Each episode dives into the latest primary literature, covering medication-focused studies across critical care and many more. We break down study designs, highlight key findings, and objectively discuss clinical implications—without the hype—so you stay informed and ready to apply new evidence in practice. Whether you’re preparing for board certification or striving for excellence in patient care, PACUPod helps you make sense of the data, one study at a time.

Britany: Welcome back to PACULit, your go-to podcast for clinical literature updates. Today, we are discussing the association between rewarming rate and survival and neurologic outcomes in accidental hypothermia. Seth, this topic is vital given how common hypothermia is in emergency and critical care settings.

Seth: Absolutely, Britany. Accidental hypothermia carries high mortality and morbidity. Rewarming is a cornerstone of treatment, but the optimal rewarming rate remains unclear. Most prior research has focused on hypothermic cardiac arrest or specific rewarming methods like extracorporeal life support, leaving a gap in understanding how rewarming rates affect a broader population of hypothermic patients.

Britany: That is correct. A recent study by Hara and colleagues, published in Critical Care Medicine in July 2025, sought to address this gap. They conducted a multicenter observational cohort study including adults with accidental hypothermia, encompassing both cardiac arrest and non-arrest patients. Their focus was on the early-phase rewarming rate—that is, how quickly core temperature rose during initial treatment—and its impact on in-hospital survival and neurologic outcomes at discharge.

Seth: Their methodology involved stratifying patients by rewarming rate, comparing slower versus faster rewarming groups. Importantly, they adjusted for potential confounders such as age, initial core temperature, comorbidities, and cardiac arrest status using multivariable logistic regression. This approach helped isolate the effect of rewarming speed on clinical outcomes.

Britany: The key finding was that faster early-phase rewarming was associated with improved survival and better neurologic outcomes at discharge. Conversely, slower rewarming correlated with higher mortality. This challenges the traditional caution against rapid rewarming due to concerns about arrhythmias and hemodynamic instability.

Seth: However, the study also highlighted that rapid rewarming carries risks in certain subgroups. Extracorporeal methods, such as extracorporeal membrane oxygenation, or ECMO, can rewarm patients at rates of four to five degrees Celsius per hour, which is faster than conventional methods. Yet, this rapid rewarming may not benefit all patients, particularly older individuals or those who are hemodynamically unstable.

Britany: Exactly. Their subgroup analyses demonstrated that ECMO-enabled faster rewarming did not necessarily improve survival in elderly or unstable patients. This suggests that patient-specific factors and initial clinical status may predict outcomes more strongly than the rewarming method alone.

Seth: This aligns with prior research. For example, Watanabe and colleagues in 2019 found that slower rewarming increased mortality, but faster rewarming was associated with complications. Podsiadło’s 2021 study showed that extracorporeal life support improved survival and neurologic outcomes in hypothermic cardiac arrest patients, but its role in non-arrest patients remained unclear.

Britany: Mendrala’s 2024 study further supported the broader use of extracorporeal rewarming in hypothermic arrest patients, reporting good outcomes. Hara et al.’s study expands on this by including non-arrest patients and emphasizing the importance of the early-phase rewarming rate across the spectrum of accidental hypothermia cases.

Seth: Regarding the study population, the median age was middle-aged to elderly, with a balanced sex distribution. Elderly patients often have comorbidities that complicate rewarming. The cohort included trauma victims and individuals exposed to outdoor environments, reflecting real-world diversity.

Britany: Including both cardiac arrest and non-arrest patients broadens the applicability of the findings. However, as an observational study, causality cannot be definitively established. Confounding by indication is possible—sicker patients might receive faster or more aggressive rewarming, potentially skewing results.

Seth: The authors addressed this concern with sensitivity analyses and adjustment for confounders, but randomized controlled trials are needed to define optimal rewarming rates. Until then, clinical judgment remains paramount.

Britany: A key clinical pearl is the importance of individualizing rewarming strategies. In hemodynamically stable patients with moderate hypothermia, faster rewarming may improve survival and neurologic outcomes. Conversely, in elderly or unstable patients, slower and more controlled rewarming might be safer.

Seth: Monitoring during rewarming is critical. Rapid temperature changes can precipitate arrhythmias, electrolyte disturbances, and hemodynamic instability. Continuous cardiac monitoring and frequent electrolyte assessments, especially of potassium and magnesium, are essential.

Britany: Drug interactions also warrant attention. Patients on antiarrhythmic agents or beta blockers may be more susceptible to arrhythmias during rewarming. Additionally, hypothermia affects drug metabolism, so dosing adjustments may be necessary.

Seth: In trauma patients, hypothermia and rewarming can exacerbate coagulopathy. Therefore, balancing rewarming speed with bleeding risk presents another clinical challenge.

Britany: Regarding rewarming modalities, conventional methods include passive external warming, warm blankets, and warmed intravenous fluids. Extracorporeal methods like ECMO offer rapid core rewarming but require specialized resources and expertise.

Seth: The study suggests that the benefits of extracorporeal methods may be limited to younger patients or those with cardiac arrest. For other patients, conventional methods with moderate rewarming rates might be preferable.

Britany: The focus on early-phase rewarming rate rather than total rewarming duration highlights a critical therapeutic window during which temperature correction most influences outcomes.

Seth: This supports protocols that define target rewarming rates tailored to patient status—generally around one to two degrees Celsius per hour in stable patients, with adjustments as clinically indicated.

Britany: The authors call for prospective trials to refine these targets and to explore the timing and criteria for initiating extracorporeal rewarming. Current guidelines rely heavily on limited evidence and expert opinion.

Seth: Such trials could also investigate interactions between rewarming rate, modality, and adjunctive therapies such as sedation, vasopressors, and electrolyte management.

Britany: To summarize, Hara and colleagues’ study provides valuable insights into the relationship between early-phase rewarming rate and outcomes in accidental hypothermia. Faster, controlled rewarming benefits many patients, but individual patient factors and modality choice remain key considerations.

Seth: It reinforces that hypothermia management is not one-size-fits-all. Careful assessment, vigilant monitoring, and individualized strategies optimize survival and neurologic recovery.

Britany: Before we close, Seth, it is worth emphasizing the importance of prehospital care in accidental hypothermia. Early recognition and gentle handling during transport can prevent further heat loss and avoid triggering arrhythmias.

Seth: Absolutely, Britany. Prehospital providers should focus on insulating the patient, minimizing movement, and avoiding rough handling. Even simple measures such as removing wet clothing and applying dry blankets can make a significant difference before hospital arrival.

Britany: Once in the hospital, multidisciplinary coordination is vital. Emergency physicians, intensivists, cardiologists, and perfusionists need to collaborate closely, especially when considering extracorporeal rewarming.

Seth: The decision to initiate extracorporeal life support requires weighing risks and benefits, resource availability, and patient preferences when possible. Early consultation with specialized teams can streamline care.

Britany: Post-rewarming care is also critical. Patients may experience rebound hypothermia or complications such as acute kidney injury or infection. Close monitoring in an intensive care setting ensures timely intervention.

Seth: Finally, education and protocol development at the institutional level can standardize hypothermia management, incorporating evidence like Hara et al.’s findings to improve outcomes across centers.

Britany: Continuous quality improvement initiatives and data collection will help refine best practices over time.

Seth: Thanks for the insightful discussion, Britany. And thank you to our listeners for joining us on PACULit. Be sure to review Hara and colleagues’ study in Critical Care Medicine, July 2025, and watch for upcoming trials that will clarify these important clinical questions.

Britany: Take care, everyone. Stay safe and keep advancing your knowledge and patient care skills.

Seth: Until next time, stay curious and keep integrating the latest evidence to improve patient outcomes.